SCHEMBL5065232

SCHEMBL5065232

Nc1nc(=O)[nH]cc1-c1ccco1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 10/20 0.43
ADORA2A P29274 9/20 0.43
ADORA2B P29275 3/20 0.42
KDM4E B2RXH2 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
HSD17B10 Q99714 3/20 0.40
RECQL P46063 3/20 0.40
HPGD P15428 3/20 0.40
PKM P14618 2/20 0.40
BLM P54132 2/20 0.40
POLB P06746 2/20 0.40
ALOX15 P16050 2/20 0.40
BRCA1 P38398 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5064949 0.74 IMPDH2 (0.37)
SCHEMBL7364092 0.74 PDPK1 (0.47) ADORA1ADORA2AADORA2BKDM4EMEN1
SCHEMBL3485241 0.73 PARP1 (0.47) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL5069316 0.71 BRD4 (0.36) ADORA1ADORA2APDPK1
SCHEMBL5065086 0.71 IMPDH2 (0.44) ADORA1ADORA2ASTK4STK3TMIGD3
SCHEMBL28457537 0.70 ADORA2A (0.47) ADORA1ADORA2AADORA2BKDM4EMEN1
SCHEMBL4563349 0.69 XDH (0.51) ADORA1ADORA2AADORA2BKMT2AALDH1A1
SCHEMBL10965948 0.68 ADORA2A (0.45) ADORA1ADORA2AADORA2BKDM4EMEN1
SCHEMBL4629034 0.68 ALDH1A1 (0.53) ADORA1ADORA2AADORA2BKDM4EMEN1
SCHEMBL5069269 0.68 NPC1 (0.49) ADORA1ADORA2AADORA2BKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-10-23 US claimed
WO-2006076102-A2 FLUORESCENT NUCLEOSIDE ANALOGS THAT MIMIC NATURALLY OCCURRING NUCLEOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-07-20 WO claimed
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-10-23 US disclosed
WO-2006076102-A2 FLUORESCENT NUCLEOSIDE ANALOGS THAT MIMIC NATURALLY OCCURRING NUCLEOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides NSUN2, NSUN3, NCL ADORA1 436/4885ADORA2A 243/4885ADORA2B 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.